USCAP 2025 Daily Update – Day 3 Recap with Dr. Aleksandra Zuraw
In this episode of the Digital Pathology Podcast, I bring you Day 3 insights live from USCAP 2025—from moderating the MUSE panel on slide-free imaging to exploring regulatory strategies, tech innovations, and collaborations across the digital pathology community.
Get an inside look at how direct-to-digital pathology is transforming workflows, how companies like Techcyte are streamlining AI applications, and why regulatory strategy is as crucial as your scanning tech.
🔬 Key Topics Covered:
[00:00:00] Behind the scenes: MUSE panel highlights and audience turnout
[00:02:00] Slide-free imaging and concordance studies with Dr. Levenson and Dr. Rao
[00:03:00] Regulatory insights from Esther Abels on digital pathology FDA strategy
[00:05:00] Poster struggles, TikTok pathology posters, and missed moments
[00:07:00] Techcyte’s new Fusion platform and use across cellular imaging departments
[00:08:00] On-the-floor interviews with thought leaders and innovators
[00:10:00] Where does glassless imaging fit into your workflow?
[00:12:00] Collaboration opportunities and global connections at the MUSE booth
[00:13:00] Final thoughts on community, education, and digital pathology’s future
🩺 Why This Episode Matters: Day 3 was packed with inspiration, breakthroughs, and powerful conversations. Whether you’re navigating regulatory approval, researching AI integration, or figuring out how slide-free imaging fits into your diagnostic flow, this update offers real-world insight from experts shaping the future of pathology.
🎧 Listen now for highlights, reflections, and what’s next at USCAP 2025!
Podden och tillhörande omslagsbild på den här sidan tillhör
Aleksandra Zuraw, DVM, PhD. Innehållet i podden är skapat av Aleksandra Zuraw, DVM, PhD och inte av,
eller tillsammans med, Poddtoppen.